Surgical Treatment Of Patients With Oculocutaneous Albinism With The Use Of Artificial Iris.

According to the World Health Organization, oculocutaneous albinism occurs in 1 out of 20 000 people in Europe and North America. Congenital changes in the organ of vision in albinism lead to a significant decrease in the visual functions of patients, worsening their quality of life. This article was based on the examination and treatment of 2 patients suffering from oculocutaneous albinism, which is characterized by hypopigmentation of the iris and retinal pigment epithelium of the retina, foveolar hypoplasia, low visual acuity, nystagmus, strabismus and excruciating photophobia. An artificial iris with the fixation in the capsular bag in the first patient, and in the ciliary sulcus in the second were implanted.

In both patients complaints of photophobia and optical phenomena have ceased. Visual acuity increased to 20/100 and remained without regression throughout the entire period of observation. Intraocular pressure and hydrodynamic parameters also remained stable throughout the observation period. The artificial irises were observed by ultrabiomicroscopy and remained in a stable position both when it was implanted in the capsule bag, and when it was seamlessly fixed in the ciliary sulcus.

The surgical interventions relieved patients from glare, at the same time improved postoperative distance visual acuity without correction, helped to achiev a pronounced cosmetic effect and rapid visual rehabilitation. Artificial irises have proven to be a safe and effective way to treat patients with oculocutaneous albinism.